UK Retail Pharmacy Market Analysis Report 2022 to 2030

UK Retail Pharmacy Market Analysis

$ 3999

UK Retail Pharmacy Market is projected to grow from $27 Bn in 2022 to $39.59 Bn by 2030, registering a CAGR of 4.9% during the forecast period of 2022-30. The development of novel medications for complex conditions in fields including cancer, respiratory, and infectious diseases, supported by NICE appraisals and guidelines, has been the primary driver of growth in the UK retail pharmacy market. Some key players in the UK retail pharmacy market include Boots UK, Lloyds Pharmacy, Well Pharmacy, Superdrug, and Rowlands Pharmacy.

ID: IN10GBPH021 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Shivam Zalke

Buy Now

UK Retail Pharmacy Market Executive Summary

UK Retail Pharmacy Market is projected to grow from $27 Bn in 2022 to $39.59 Bn by 2030, registering a CAGR of 4.9% during the forecast period of 2022-30.

The retail pharmacy market in the UK is a highly competitive and regulated industry. The market is dominated by a few large chains, such as Boots and Lloyds Pharmacy, as well as smaller independent pharmacies. The National Health Service (NHS) plays a major role in the market through the National Health Service (Pharmaceutical Services) Regulations, which regulate the prices of prescription drugs. Additionally, the NHS also provides funding for community pharmacies to provide a range of health services, such as flu vaccinations and medication reviews.

In recent years, there has been a trend toward the expansion of online pharmacies, which has led to increased price competition. Additionally, the government has also implemented policies to encourage the growth of smaller independent pharmacies and increase the number of pharmacies in underserved areas. Healthcare reform also plays a role in the UK pharmacy market, with a focus on increasing the role of community pharmacy in the primary care system.

UK retail pharmacy market analysis report 2022 to 2030

Market Dynamics

Market Drivers

Some key drivers of the UK retail pharmacy market include an aging population, an increase in chronic disease, and changes in healthcare policy. Additionally, the growing trend of self-care and consumer demand for convenience also contribute to the growth of the retail pharmacy market. Government funding for the National Health Service (NHS) and changes in regulations also have a significant impact on the market.

Market Restraints

Some key restraints of the UK retail pharmacy market include the increasing competition from online pharmacies and supermarkets, as well as pricing pressures from the government and insurance companies. Additionally, the increasing regulation and scrutiny of the industry can also act as a restraint on the market. Another restraint is the increasing pressure to reduce costs, which can lead to reduced profitability and the closure of independent pharmacies. Also, the increasing trend of remote consultations and the shift of prescriptions online can also be seen as a restraint for the retail pharmacy market.

Competitive Landscape

Key Players

Some key players in the UK retail pharmacy market include:

Boots UK,
Lloyds Pharmacy,
Well Pharmacy,
Superdrug, and
Rowlands Pharmacy

Healthcare Policies and Regulatory Landscape

The UK retail pharmacy market is heavily regulated by the government through the General Pharmaceutical Council (GPhC) and the Medicines and Healthcare products Regulatory Agency (MHRA). These organizations are responsible for ensuring that pharmacies and pharmacy staff meet certain standards and comply with relevant laws and regulations.

The National Health Service (NHS) also plays a significant role in the retail pharmacy market through its funding and purchasing of drugs. The NHS negotiates prices with pharmaceutical manufacturers and sets reimbursement prices for drugs dispensed in community pharmacies.

In recent years, the UK government has introduced several policies aimed at reducing costs and improving the efficiency of the healthcare system. For example, the NHS has implemented the Community Pharmacy Contractual Framework (CPCF) which aimed to reduce costs and increase the use of community pharmacies in primary care. Also, the government has introduced the Electronic Prescription Service (EPS) which aims to shift the prescribing and dispensing process online, potentially reducing costs and increasing efficiency.

In summary, the retail pharmacy market in the UK is heavily influenced by government policies and regulations, and changes in these policies can have a significant impact on the market.

Overall, the UK retail pharmacy market is expected to continue growing in the coming years, driven by factors such as an aging population and an increase in chronic diseases.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Retail Pharmacy Market Segmentation

Pharmacy Product

It mainly includes Pharmaceutical products and it provides information for medical treatments.

Prescription
OTC

Pharmacy Type

Hospital Pharmacy
Retail Pharmacy
Chain
Independent
Others
ePharmacy
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.